Traders, Media Seek FOIA Docs about India Pharma

by Randy E. Miller | May 30, 2024 | FDA, FOIA, Hedge Funds, News Media, Pharmaceuticals, Stock Market

FOIAengine: Requests Show FDA Still Under Pressure  This week, we’re taking a closer look at the numerous Freedom of Information Act requests recently filed with the Food and Drug Administration concerning the problematic India pharmaceutical industry. As we noted in...

An Anti-Biden Group Goes All In on FOIA Requests

by John A. Jenkins | May 16, 2024 | FDA, FOIA, Litigation, Non-Profits, Politics, SEC

FOIAengine:  What Does the American Accountability Foundation Want to Know – and Why? This week we’re taking a look at the more than 100 Freedom of Information Act requests recently filed by the non-profit American Accountability Foundation.  This group, a pugnacious...

Forensic FOIA: BLS “Super Users” Are a Case Study

by John A. Jenkins | Apr 30, 2024 | FOIA, Hedge Funds, Stock Market

FOIAengine:  Traders Had an Inside Track on the CPI.  Journalists Used FOIA to Expose It. Today’s story is about the Bureau of Labor Statistics, which calculates the all-important Consumer Price Index.  It’s also a cautionary tale about how a select few on Wall Street...

Journalists Signal Upcoming Story Lines with FOIA Requests

by Randy E. Miller | Apr 24, 2024 | FDA, FOIA, News Media, SEC

FOIAengine: Insights From the Latest FDA and SEC Requests  News media outlets are among the most prolific submitters of FOIA requests to federal agencies. These requests signal – in real time – the stories that journalists are researching and writing. To illustrate...

A J&J Heart Pump is Linked to Far More Deaths than Previously Reported. Did FOIA Requests Send a Signal?

by John A. Jenkins | Apr 11, 2024 | FDA, FOIA, Medical Devices

FOIAengine:  As Deaths Mounted, J&J “Promised to Correct” – and Sought FDA Records Johnson & Johnson (NYSE: JNJ) proudly calls itself “the world’s largest and most diversified healthcare products company.”  The company had $85 billion in sales last year, and...

Hype and Hope: Brain-chip Progress Evokes Investigations, Controversy

by John A. Jenkins | Apr 3, 2024 | FDA, FOIA, Law Firms, Medical Devices

FOIAengine: Neuralink’s High Profile Makes It a Target It was a Musk Moment unlike any other:  Two weeks ago, the first human participant in Neuralink’s brain-implant trials took the stage to show how he could play chess by imagining where he wanted the pieces to go. ...